119 related articles for article (PubMed ID: 27765006)
1. Rigler Sign in a Child With Posttransplant Lymphoproliferative Disease: A Sign That Should Not Be Missed.
Shakibazad N; Kamali K; Honar N; Bordbar M; Mohazabieh E
Exp Clin Transplant; 2018 Jun; 16(3):352-354. PubMed ID: 27765006
[TBL] [Abstract][Full Text] [Related]
2. Rigler on the roof. Rigler's sign.
Simpson J; Humes DJ; O'Rourke EJ; James PD; Acheson AG
Gut; 2008 Jun; 57(6):798, 836. PubMed ID: 18477680
[No Abstract] [Full Text] [Related]
3. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
[TBL] [Abstract][Full Text] [Related]
4. Intestinal perforation associated with rituximab therapy for post-transplant lymphoproliferative disorder after liver transplantation.
Cornejo A; Bohnenblust M; Harris C; Abrahamian GA
Cancer Chemother Pharmacol; 2009 Sep; 64(4):857-60. PubMed ID: 19588139
[TBL] [Abstract][Full Text] [Related]
5. Treatment dilemma for survivors of rituximab-induced bowel perforation in the setting of post-transplant lymphoproliferative disorder.
Sullivan BJ; Kim GJ; Sara G
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567238
[TBL] [Abstract][Full Text] [Related]
6. [Post-transplantation lymphoproliferative disorder in childhood].
Stréhn A; Szőnyi L; Kriván G; Kovács L; Reusz G; Szabó A; Rényi I; Kovács G; Dezsőfi A
Orv Hetil; 2014 Feb; 155(8):313-8. PubMed ID: 24534879
[TBL] [Abstract][Full Text] [Related]
7. High-intensity chemotherapy and rituximab for the treatment of posttransplant lymphoproliferative disorder.
Chen RW; Sweetenham JW
Am J Clin Oncol; 2006 Apr; 29(2):211-2. PubMed ID: 16601446
[No Abstract] [Full Text] [Related]
8. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
Tai CC; Curtis JL; Szmuszkovicz JR; Horn MV; Ford HR; Woo MS; Wang KS
J Pediatr Surg; 2008 Dec; 43(12):2174-7. PubMed ID: 19040929
[TBL] [Abstract][Full Text] [Related]
9. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
Deng Z; Jiang L; Zhou T; Shen C; Chen Q; Xia Q
Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):579-82. PubMed ID: 25224233
[TBL] [Abstract][Full Text] [Related]
10. Multifocal cranial plasmablastic lymphoma as a rare manifestation of posttransplant lymphoproliferative disorder.
Jenabi A; Mooraki A; Jabbari M; Shayanfar N; Ghods AJ; Ziari MB; Bastani B
Iran J Kidney Dis; 2012 Sep; 6(5):380-5. PubMed ID: 22976265
[TBL] [Abstract][Full Text] [Related]
11. Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
Trappe RU; Dierickx D; Zimmermann H; Morschhauser F; Mollee P; Zaucha JM; Dreyling MH; Dührsen U; Reinke P; Verhoef G; Subklewe M; Hüttmann A; Tousseyn T; Salles G; Kliem V; Hauser IA; Tarella C; Van Den Neste E; Gheysens O; Anagnostopoulos I; Leblond V; Riess H; Choquet S
J Clin Oncol; 2017 Feb; 35(5):536-543. PubMed ID: 27992268
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
[TBL] [Abstract][Full Text] [Related]
13. Liver transplant for Crigler-Najjar syndrome.
Guru FR; Sibal A
Indian Pediatr; 2010 Mar; 47(3):285-6. PubMed ID: 20371903
[No Abstract] [Full Text] [Related]
14. Posttransplant lymphoproliferative disorder with lung involvement in a renal transplant recipient.
Mirza EI; Mutluay R; Suyani E; Okyay GU; Akyurek N; Aki SZ; Derici U; Arinsoy T
Exp Clin Transplant; 2011 Dec; 9(6):425-8. PubMed ID: 22142053
[TBL] [Abstract][Full Text] [Related]
15. DA-EPOCH-R for post-transplant lymphoproliferative disorders.
DeStefano CB; Malkovska V; Rafei H; Shenoy A; Fitzpatrick K; Aggarwal A; Catlett JP
Eur J Haematol; 2017 Sep; 99(3):283-285. PubMed ID: 28509395
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: a remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD).
Giraldi E; Provenzi M; Fiocchi R; Colledan M; Cornelli P; Torre G; Rambaldi A; Conter V
Pediatr Blood Cancer; 2011 Aug; 57(2):324-8. PubMed ID: 21294246
[TBL] [Abstract][Full Text] [Related]
17. Recurrent posttransplant lymphoproliferative disorder involving the larynx and trachea: case report and review of the literature.
Banks CA; Meier JD; Stallworth CR; White DR
Ann Otol Rhinol Laryngol; 2012 May; 121(5):291-5. PubMed ID: 22724273
[TBL] [Abstract][Full Text] [Related]
18. Cannabis use in the young and stercoral perforation.
Singh HK; Young T; Srinivasaiah N; Marcelle M
Br J Hosp Med (Lond); 2019 May; 80(5):i. PubMed ID: 31059327
[No Abstract] [Full Text] [Related]
19. Soft Palate Ulcer: An Unusual Presentation of a Posttransplant Lymphoproliferative Disorder.
Bahmanyar M; Shakibazad N; Imanieh MH; Dehghani SM
J Pediatr Hematol Oncol; 2017 Mar; 39(2):e97-e99. PubMed ID: 27918349
[TBL] [Abstract][Full Text] [Related]
20. Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy.
Gross TG; Hinrichs SH; Winner J; Greiner TC; Kaufman SS; Sammut PH; Langnas AN
Ann Oncol; 1998 Mar; 9(3):339-40. PubMed ID: 9602271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
